Anti-monopoly is still a new concept in China, but transactional reviews are increasing in importance as the country ascends to the world stage. But it is still unclear what triggers a review, what the process involves and how reviews are changing
New draft Regulations will allow companies listed in China to offer stock ownership plans that could increase staff retention, but without additional incentives employees may be reluctant to participate
I am suing a company in its home town. The company is a big employer. How can I avoid a situation where lots of negative publicity is created that could put pressure on the judge hearing the case?
The limit on the total of the holdings of the A shares of a single listed company by all QFIIs is now increased from 20% to 30% of the listed company's total shares. The qualification thresholds for QFIIs have also been relaxed.
Foreign-invested partnerships have been around for two years and are starting to become more attractive as investors seek alternative vehicles. The structure is easy to set up and offers unparalleled tax benefits, but investors should be cautious of their liabilities
China has identified a group of strategic emerging industries that it believes can help drive innovation and growth over the next 10 years. Benjamin Bai and Cecily Zhang explain why foreign investors need to understand the implications of this initiative
The NDRC has proposed raising the threshold at which foreign-invested projects need approval, while Shanghai has introduced a subsidy for multinationals that set up their headquarters in the city and awarded tax breaks for R&D work
Shanghai was the first city to release details of its pilot carbon trading market as part of a national policy to encourage a low carbon economy, but questions remain over how the NDRC will regulate the trading platforms
The Measures have been revised to pave the way for seed funding requiring the size of the fund to be at least Rmb50 million and the number of fundholders to be at least 200.
Multinational pharmaceutical companies are facing strains on their revenues as many of their patents covering their biggest selling medicines are due to expire. But in China an SPC ruling on pen designs has shown that other IP rights could come to the rescue